Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

ClinicalTrials.gov ID: NCT00032643

Public ClinicalTrials.gov record NCT00032643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CSP #526 - A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Study identification

NCT ID
NCT00032643
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Department of Veterans Affairs
Federal
Enrollment
150 participants

Conditions and interventions

Interventions

  • DITPA Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Nov 30, 2006
Completion
Nov 30, 2006
Last update posted
Nov 4, 2013

2004 – 2006

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Southern Arizona VA Health Care System Tucson Arizona 85723
VA Greater Los Angeles Healthcare System, West LA West Los Angeles California 90073
VA Eastern Colorado Health Care System, Denver Denver Colorado 80220
VA Medical Center, Minneapolis Minneapolis Minnesota 55417
VA Medical Center, Cleveland Cleveland Ohio 44106
Ralph H Johnson VA Medical Center, Charleston Charleston South Carolina 29401-5799
VA South Texas Health Care System, San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00032643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00032643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →